Diapharma Has You Covered for Your COVID-19 and Thrombosis Research Needs
Posted: August 11, 2020
Your source for COVID-19 related thrombosis and fibrinolysis research products
New! SARS-CoV-2 ELISAs for detection of IgG or IgA antibodies
- Ideal for COVID-19 research, epidemiological studies, and vaccine development
- Nucleocapsid-based (N-Protein) target – tested at ~100% specificity
- Unique- IgA is the major antibody class found in mucosal membranes and is a major factor of immunity for many other respiratory pathogens.
- Open-system, standard ELISAs that require no special readers and can be automated for higher throughput
- Manufactured in Germany and submitted for EUA to the FDA by Gold Standard Diagnostics
We have you covered for COAGULATION, FIBRINOLYSIS, ANTICOAGULATION, and IVIG safety testing/QC.
Diapharma is your trusted provider for the highest quality products related to all things bleeding and clotting.
Technothrombin® TGA* thrombin generation testing
Fibrinolytic Markers*: PAI-1, tPA, PAP
Inflammation Marker ELISAs*
Testing for Immunoglobulin (IVIG) preparations*: PKA, FXIa, TGA
*Research use only in the U.S. and Canada
Contact us today to learn more.
Our scientific support staff is happy to discuss any product in our lineup.
Diapharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069